Napleton Auto Group Achieves Record Score in 2025 Dealer Group Study Measuring Response to Website Customers
MONTEREY, Calif.--(BUSINESS WIRE)--May 5, 2025--
Napleton Automotive Group dealerships ranked highest in the 2025 Pied Piper PSI ® Internet Lead Effectiveness ® (ILE ® ) Auto Dealer Group Study, which measured responsiveness to internet sales leads coming through dealership websites. Following Napleton were Ciocca Automotive, Herb Chambers Auto Group, and Berkshire Hathaway Automotive.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250504671700/en/
Source: 2025 Pied Piper Auto Dealer Group Internet Lead Effectiveness Study (USA)
Pied Piper submitted customer inquiries through 2,105 automobile dealership websites representing 26 of the largest USA auto dealer groups. Each inquiry asked a specific question about a vehicle in inventory and included a new customer name, email address, and local telephone number. Pied Piper then evaluated the speed and quality of dealership responses sent by email, telephone, text, and chat over the next 24 hours. Each group's overall ILE Score is a combined average of their individual dealership ILE performances. ILE evaluations consist of over 20 differently weighted measurements, based on best practices that are mathematically most likely to generate sales, combining into an overall ILE score ranging from 0 to 100.
Napleton Achieved Highest Score on Record, What Behaviors Drove This Accomplishment?
2025 marks the fourth year in a row that Napleton Automotive Group achieved the top score in the annual ILE Auto Dealer Group study. Napleton improved their average score by four points for 2025, reaching an average ILE score of 91, the highest average ILE score on record and becoming the first brand or group to achieve an average ILE score in the 90s.
How Did the Industry Perform Over the Past Year?
Average dealer group performance increased only slightly – up one point - over last year, but performance has improved substantially over the past three years. Nine groups achieved average ILE scores over 70 in 2025, while three years ago in 2022 only two groups achieved ILE scores over 70.
Despite the improvement, there remains a large 50-point spread in ILE score performance in the 2025 study, with nine dealer groups improving their ILE score over the past year and seven groups declining in overall score.
Dealer Groups that Improved:
Nine of the 26 dealer groups studied in 2025 improved their ILE scores over the past year, on average increasing by 5 points, with two groups improving by 10 points. The most notable improved behaviors of these nine dealer groups were more appointments offered, more questions answered by texting, and answering questions faster on average than last year.
Dealer Groups that Declined:
Seven of the 26 dealer groups in the 2025 study had lower ILE scores than the previous year, with an average decrease of -4 points and two groups declining -8 or more points. Dealer groups that scored lower in 2025 were less likely, compared to 2024, to 'do both fast,' less likely to respond by phone, and less likely to use texting to answer questions.
Comparing Top Dealer Groups to the Overall Auto Industry Using the '80/40' Rule:
Compared to the overall auto industry, top performing dealer groups tend to be much quicker and more effective at responding to online customers. In this year's ILE studies, 73% of the dealerships from the top five highest scoring dealer groups scored above 80 (providing quick and thorough personal responses), compared to only 40% of the dealerships for the auto industry overall. Similarly, only 6% of the dealerships from the top five dealer groups scored under 40 (failing to personally respond to website customers), compared to 19% of the dealerships throughout the total auto industry.
'Identifying a brand or group's dealerships scoring under 40 and over 80 is an efficient way to determine where improvement efforts should be focused,' said Cameron O'Hagan, Pied Piper's Vice President of Metrics and Analytics. 'Historically, we have found that dealerships that improve their ILE performance from scoring under 40 to scoring over 80 on average sell 50% more units from the same quantity of website customer leads.'
2025 Dealer Group Performance Compared:
Response to customer web inquiries in the 2025 study had large variations by group, as shown by these examples:
Why Was This Study Conducted?
'Modern customers visit dealership websites first, and today's sales success is driven by how the dealerships respond,' said O'Hagan. 'The difficulty is that the website customer experiences are often invisible or distorted by traditional dashboards, which makes this portion of dealership performance easy to overlook.'
For more than 15 years, Pied Piper has independently published annual industry studies that rank the omnichannel performance of brands and dealer groups. These studies track how industry performance changes over time and let clients understand how their own performance compares.
Pied Piper clients order ongoing Prospect Satisfaction Index ® (PSI ® ) measurement and reporting – internet, telephone or in-person – for their dealerships, as tools to improve and maintain omnichannel sales and service effectiveness. Pied Piper clients have found that the key to driving dealership improvement is showing what sales and service customers are really experiencing – which is often a surprise.
About Pied Piper Management Company, LLC
Monterey, California - based Pied Piper helps brands and national retailer groups improve the omnichannel sales & service performance of their retailers.
Pied Piper's PSI process applies data science analytics to determine the omnichannel sales and service best practices most likely to drive unit sales and loyalty. PSI then uses a combination of artificial intelligence, machine learning and human actors to measure and report how effectively retail locations follow those best practices.
Examples of other recent Pied Piper PSI studies include the 2025 Internet Lead Effectiveness ® (ILE ® ) Auto Industry Study (Subaru was ranked first), the 2024 Service Telephone Effectiveness ® (STE®) Auto Industry Study (Honda's Acura brand was ranked first), and the 2024 Telephone Lead Effectiveness ™ (TLE ™ ) Pontoon Boat Industry Study (BRP's Sea-Doo brand ranked first).
For more information about Prospect Satisfaction Index ® study results or to apply ongoing PSI measurement and reporting to improve performance, go to www.piedpiperpsi.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20250504671700/en/
CONTACT: Pied Piper
Ryan Scott
[email protected]
(831) 648-1075
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA
INDUSTRY KEYWORD: MARKETING ONLINE RETAIL RETAIL COMMUNICATIONS AUTOMOTIVE GENERAL AUTOMOTIVE
SOURCE: Pied Piper Management Company, LLC
Copyright Business Wire 2025.
PUB: 05/05/2025 12:01 AM/DISC: 05/05/2025 12:01 AM
http://www.businesswire.com/news/home/20250504671700/en
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Anteris Appoints David Roberts and Gregory Moss to its Board of Directors
New Directors Bring Extensive NASDAQ Expertise Across Legal, Operational and Corporate Leadership Capacities MINNEAPOLIS and BRISBANE, Australia, June 09, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today announced the appointments of Mr. David Roberts and Mr. Gregory Moss to its Board of Directors. The Company also announced the resignation of Dr. Wenyi Gu from the Board upon completion of his term as an Australia-based non-executive director. 'On behalf of the management team and Board, I am delighted to welcome David and Gregory to the Company' commented John Seaberg, Chairman of Anteris. 'On the heels of our Q4 2024 listing onto NASDAQ, and as we ramp-up activities to launch the DurAVR® THV global, pivotal clinical trial (the "PARADIGM Trial"), we are excited to enhance the leadership team with two highly accomplished, U.S. based, healthcare executives as the company transitions to its next phase of growth. I also wish to extend gratitude to Dr. Gu for his commitment and contributions to the company over the course of his tenure as a member of the Board and wish him well on his future endeavors.' Mr. David Roberts is currently President of LeMaitre Vascular, Inc. (NASDAQ: LMAT), a position he has held since 2007. He joined LeMaitre in 1997 as Vice President of Business Development and was promoted to Chief Financial Officer in 2000. Prior to LeMaitre, Mr. Roberts served as Vice President of Development for BUCA, Inc. from 1994 to 1997, and prior to that as Associate of HarbourVest Partners from 1992 to 1994. Mr. Roberts received a Bachelor of Arts in Business Economics and History from Brown University and a Master of Business Administration from the Stanford University Graduate School of Business. Mr. Roberts serves as a director of LeMaitre Vascular, Inc., Lexington Medical, Inc. and Parasole Restaurant Holdings, Inc. Mr. Gregory Moss serves as Chief Business and Legal Officer, as well as Corporate Secretary and Chief Compliance Officer of Evommune, Inc. Prior to Evommune, Mr. Moss served as Executive Vice President, General Counsel, and Corporate Secretary, Chief Compliance Officer at Kadmon, a Sanofi Company, where he led legal, compliance, and business development operations, culminating in Kadmon's $1.9 billion acquisition in 2021. Prior to joining Kadmon in 2012, Mr. Moss served as a solicitor in the corporate risk department of a large Australian law firm and as an associate at a boutique law firm and hedge fund in New York, where he focused on complex litigation and event-driven outcomes. Mr. Moss currently serves on the board of Vitls, Inc. Mr. Moss earned a BA and an LLB from Macquarie University, Australia, and is a member of the Bar Associations of New York, USA, and New South Wales, Australia, with admissions before the Supreme Court of the United States of America; Southern District of New York; Supreme Court of New South Wales, Australia; and High Court of Australia. Mr. Roberts and Mr. Moss will help guide Anteris through its next phase of growth, with the upcoming global pivotal PARADIGM study in 3Q2025 towards the ultimate U.S. and EMA licensure of the DurAVR® THV for patients with aortic stenosis. About Anteris Anteris Technologies Global Corp. (NASDAQ: AVR, ASX: AVR) is a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Founded in Australia, with a significant presence in Minneapolis, USA, Anteris is a science-driven company with an experienced team of multidisciplinary professionals delivering restorative solutions to structural heart disease patients. Anteris' lead product, the DurAVR® Transcatheter Heart Valve (THV), was designed in partnership with the world's leading interventional cardiologists and cardiac surgeons to treat aortic stenosis – a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR® THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow. DurAVR® THV is made using a single piece of molded ADAPT® tissue, Anteris' patented anti-calcification tissue technology. ADAPT® tissue, which is FDA-cleared, has been used clinically for over 10 years and distributed for use in over 55,000 patients worldwide. The DurAVR® THV System is comprised of the DurAVR® valve, the ADAPT® tissue, and the balloon-expandable ComASUR® Delivery System. For more information: Investor Relations investor@ OrmsbyAnteris Technologies Global Corp.+61 1300 550 310 | +61 7 3152 3200 Investor Relations (US)mchatterjee@ Chatterjee, Life Science Group+1 917 330 4269WebsiteXFacebookLinkedIn in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Anteris Appoints David Roberts and Gregory Moss to its Board of Directors
New Directors Bring Extensive NASDAQ Expertise Across Legal, Operational and Corporate Leadership Capacities MINNEAPOLIS and BRISBANE, Australia, June 09, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today announced the appointments of Mr. David Roberts and Mr. Gregory Moss to its Board of Directors. The Company also announced the resignation of Dr. Wenyi Gu from the Board upon completion of his term as an Australia-based non-executive director. 'On behalf of the management team and Board, I am delighted to welcome David and Gregory to the Company' commented John Seaberg, Chairman of Anteris. 'On the heels of our Q4 2024 listing onto NASDAQ, and as we ramp-up activities to launch the DurAVR® THV global, pivotal clinical trial (the "PARADIGM Trial"), we are excited to enhance the leadership team with two highly accomplished, U.S. based, healthcare executives as the company transitions to its next phase of growth. I also wish to extend gratitude to Dr. Gu for his commitment and contributions to the company over the course of his tenure as a member of the Board and wish him well on his future endeavors.' Mr. David Roberts is currently President of LeMaitre Vascular, Inc. (NASDAQ: LMAT), a position he has held since 2007. He joined LeMaitre in 1997 as Vice President of Business Development and was promoted to Chief Financial Officer in 2000. Prior to LeMaitre, Mr. Roberts served as Vice President of Development for BUCA, Inc. from 1994 to 1997, and prior to that as Associate of HarbourVest Partners from 1992 to 1994. Mr. Roberts received a Bachelor of Arts in Business Economics and History from Brown University and a Master of Business Administration from the Stanford University Graduate School of Business. Mr. Roberts serves as a director of LeMaitre Vascular, Inc., Lexington Medical, Inc. and Parasole Restaurant Holdings, Inc. Mr. Gregory Moss serves as Chief Business and Legal Officer, as well as Corporate Secretary and Chief Compliance Officer of Evommune, Inc. Prior to Evommune, Mr. Moss served as Executive Vice President, General Counsel, and Corporate Secretary, Chief Compliance Officer at Kadmon, a Sanofi Company, where he led legal, compliance, and business development operations, culminating in Kadmon's $1.9 billion acquisition in 2021. Prior to joining Kadmon in 2012, Mr. Moss served as a solicitor in the corporate risk department of a large Australian law firm and as an associate at a boutique law firm and hedge fund in New York, where he focused on complex litigation and event-driven outcomes. Mr. Moss currently serves on the board of Vitls, Inc. Mr. Moss earned a BA and an LLB from Macquarie University, Australia, and is a member of the Bar Associations of New York, USA, and New South Wales, Australia, with admissions before the Supreme Court of the United States of America; Southern District of New York; Supreme Court of New South Wales, Australia; and High Court of Australia. Mr. Roberts and Mr. Moss will help guide Anteris through its next phase of growth, with the upcoming global pivotal PARADIGM study in 3Q2025 towards the ultimate U.S. and EMA licensure of the DurAVR® THV for patients with aortic stenosis. About Anteris Anteris Technologies Global Corp. (NASDAQ: AVR, ASX: AVR) is a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Founded in Australia, with a significant presence in Minneapolis, USA, Anteris is a science-driven company with an experienced team of multidisciplinary professionals delivering restorative solutions to structural heart disease patients. Anteris' lead product, the DurAVR® Transcatheter Heart Valve (THV), was designed in partnership with the world's leading interventional cardiologists and cardiac surgeons to treat aortic stenosis – a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR® THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow. DurAVR® THV is made using a single piece of molded ADAPT® tissue, Anteris' patented anti-calcification tissue technology. ADAPT® tissue, which is FDA-cleared, has been used clinically for over 10 years and distributed for use in over 55,000 patients worldwide. The DurAVR® THV System is comprised of the DurAVR® valve, the ADAPT® tissue, and the balloon-expandable ComASUR® Delivery System. For more information: Investor Relations investor@ OrmsbyAnteris Technologies Global Corp.+61 1300 550 310 | +61 7 3152 3200 Investor Relations (US)mchatterjee@ Chatterjee, Life Science Group+1 917 330 4269WebsiteXFacebookLinkedIn
Yahoo
5 hours ago
- Yahoo
EVA AIR AND THE SAN FRANCISCO GIANTS TEAMED UP TO CELEBRATE HELLO KITTY® DAY AT ORACLE PARK
Co-branded jerseys, mascot appearances, and premium ticket giveaways highlighted the unique gameday. SAN FRANCISCO, June 9, 2025 /PRNewswire/ -- EVA Air was proud to join fans at Oracle Park on Sunday, June 8 for a special Hello Kitty®-themed gameday experience in partnership with the San Francisco Giants. From limited-edition collectibles to a special giveaway, in-game features and live activations, the promotion offered fans of all ages a fun-filled afternoon at the ballpark. Prior to game time, fans stopped by the EVA Air booth to enjoy interactive activities and branded giveaways. EVA Air President Clay Sun threw out the ceremonial first pitch and was joined on the field by two uniformed EVA Air flight attendants. EVA Air hosted a special giveaway during an inning break, where one lucky fan took home two Premium Economy flight tickets. The winner will have the chance to visit one destination from EVA Air's Asian routes, which include cities in Taiwan, and Southeast Asia like Bangkok, Bali, Manila, and Ho Chi Minh City, as well as Japan, South Korea, Hong Kong, Macao, and mainland China. "As a global carrier, we see immense value in partnerships that go beyond the terminal," said EVA Air President Clay Sun. "Since 2023, our collaboration with the San Francisco Giants has allowed us to connect with fans in dynamic and high-impact ways. This special game is a great example of how we continue to show up, with a continued commitment to creating standout experiences both in the skies and on the ground." "At the Giants, we are intentional about building partnerships that engage our fans and elevate the reach and relevance of both our team and our partner brands," said Steve Tseng, Senior Vice President, Partnerships at the San Francisco Giants. "Partnering with EVA Air and collaborating with Hello Kitty® allows us to reach our diverse fanbase in meaningful ways and continue to create unique experiences at Oracle Park." The first 15,000 fans who entered Oracle Park on June 8 received a co-branded Hello Kitty® Giants jersey featuring the EVA Air logo. Hello Kitty® also made a special appearance, joining the San Francisco Giants' mascot Lou Seal on the field. For more information and to learn more about EVA Air's services, visit About EVA Air:A Star Alliance member, EVA Air was founded in 1989 as Taiwan's first privately owned international airline. It is an affiliated company to global container-shipping leader Evergreen Line. It flies a fleet of more than 80 Boeing and Airbus aircraft to around 60 international destinations throughout Asia, Oceania, Europe and North America, with gateways in Los Angeles, San Francisco, Seattle, Chicago, Houston, New York, Toronto and Vancouver. Travelers can learn more about EVA and schedule, book and buy tickets at About San Francisco GiantsOne of the oldest teams in Major League Baseball, the 142-year old franchise moved to San Francisco from New York in 1958. After playing a total of 42 years in Seals Stadium and Candlestick Park, the team moved to the privately constructed, downtown ballpark on the corner of 3rd and King in 2000. The organization is widely recognized for its innovative business practices and baseball excellence having been named in the past decade the Sports Organization of the Year by Street & Smith's Sports Business Journal, Organization of the Year by Baseball America and ESPN's Sports Humanitarian Team of the Year. Oracle Park is also the only ballpark in the country to have earned Silver, Gold and Platinum LEED certification for an existing building. Since opening its gates, Oracle Park has become internationally-renowned as a premier venue in the world of both sports and entertainment. On the diamond, more than 75 million spectators have witnessed countless magical moments, including three World Series Championships (2010, 2012 & 2014), the raising of four National League Pennants and eight playoff appearances. The ballpark has also hosted some of music's biggest acts, including Lady Gaga, Beyoncé & Jay Z, Ed Sheeran, the Rolling Stones, the Eagles, Bruce Springsteen and the E-Street Band, Green Day and Billy Joel. View original content to download multimedia: SOURCE EVA Airways Corporation